Cargando…

Ralstonia mannitolilytica infections in an oncologic day ward: description of a cluster among high-risk patients

BACKGROUND: Ralstonia spp, an environmental microorganism, has been occasionally associated with healthcare infections. The aim of this study was to investigate an outbreak caused by Ralstonia mannitolilytica in oncology patients. METHODS: Case definition: Oncology outpatients attending a day ward,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucarelli, Claudia, Di Domenico, Enea Gino, Toma, Luigi, Bracco, Domenico, Prignano, Grazia, Fortunati, Maria, Pelagalli, Lorella, Ensoli, Fabrizio, Pezzotti, Patrizio, García-Fernández, Aurora, Pantosti, Annalisa, Ingrosso, Loredana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297155/
https://www.ncbi.nlm.nih.gov/pubmed/28191308
http://dx.doi.org/10.1186/s13756-017-0178-z
_version_ 1782505688447057920
author Lucarelli, Claudia
Di Domenico, Enea Gino
Toma, Luigi
Bracco, Domenico
Prignano, Grazia
Fortunati, Maria
Pelagalli, Lorella
Ensoli, Fabrizio
Pezzotti, Patrizio
García-Fernández, Aurora
Pantosti, Annalisa
Ingrosso, Loredana
author_facet Lucarelli, Claudia
Di Domenico, Enea Gino
Toma, Luigi
Bracco, Domenico
Prignano, Grazia
Fortunati, Maria
Pelagalli, Lorella
Ensoli, Fabrizio
Pezzotti, Patrizio
García-Fernández, Aurora
Pantosti, Annalisa
Ingrosso, Loredana
author_sort Lucarelli, Claudia
collection PubMed
description BACKGROUND: Ralstonia spp, an environmental microorganism, has been occasionally associated with healthcare infections. The aim of this study was to investigate an outbreak caused by Ralstonia mannitolilytica in oncology patients. METHODS: Case definition: Oncology outpatients attending a day ward, with positive blood and/or central venous catheter (CVC) culture for Ralstonia spp from September 2013 – June 2014. We analysed medical records, procedures and environmental samples. R. mannitolilytica was identified by 16S rRNA sequencing, and typed by Pulsed Field Gel Electrophoresis (PFGE); resistance to carbapenemes was investigated by phenotypic and molecular methods. RESULTS: The patients (N = 22) had different malignancies and received different therapy; all had a CVC and 16 patients presented chills and/or fever. R. mannitolilytica was isolated from both blood and CVC (n = 12) or only blood (n = 6) or CVC tips (n = 4). The isolates had indistinguishable PFGE profile, and showed resistance to carbapenems. All the isolates were negative for carbapenemase genes while phenotypic tests suggests the presence of an AmpC β-lactamase activity,responsible for carbapenem resistance. All patients had had CVC flushed with saline to keep the venous access pervious or before receiving chemotherapy at various times before the onset of symptoms. After the first four cases occurred, the multi-dose saline bottles used for CVC flushing were replaced with single-dose vials; environmental samples were negative for R. mannitolilytica. CONCLUSIONS: Although the source of R. mannitolilytica remains unidentified, CVC flushing with contaminated saline solution seems to be the most likely origin of R. mannitolilytica CVC colonization and subsequent infections. In order to prevent similar outbreaks we recommend removal of any CVC that is no longer necessary and the use of single-dose solutions for any parenteral treatment of oncology patients.
format Online
Article
Text
id pubmed-5297155
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52971552017-02-10 Ralstonia mannitolilytica infections in an oncologic day ward: description of a cluster among high-risk patients Lucarelli, Claudia Di Domenico, Enea Gino Toma, Luigi Bracco, Domenico Prignano, Grazia Fortunati, Maria Pelagalli, Lorella Ensoli, Fabrizio Pezzotti, Patrizio García-Fernández, Aurora Pantosti, Annalisa Ingrosso, Loredana Antimicrob Resist Infect Control Research BACKGROUND: Ralstonia spp, an environmental microorganism, has been occasionally associated with healthcare infections. The aim of this study was to investigate an outbreak caused by Ralstonia mannitolilytica in oncology patients. METHODS: Case definition: Oncology outpatients attending a day ward, with positive blood and/or central venous catheter (CVC) culture for Ralstonia spp from September 2013 – June 2014. We analysed medical records, procedures and environmental samples. R. mannitolilytica was identified by 16S rRNA sequencing, and typed by Pulsed Field Gel Electrophoresis (PFGE); resistance to carbapenemes was investigated by phenotypic and molecular methods. RESULTS: The patients (N = 22) had different malignancies and received different therapy; all had a CVC and 16 patients presented chills and/or fever. R. mannitolilytica was isolated from both blood and CVC (n = 12) or only blood (n = 6) or CVC tips (n = 4). The isolates had indistinguishable PFGE profile, and showed resistance to carbapenems. All the isolates were negative for carbapenemase genes while phenotypic tests suggests the presence of an AmpC β-lactamase activity,responsible for carbapenem resistance. All patients had had CVC flushed with saline to keep the venous access pervious or before receiving chemotherapy at various times before the onset of symptoms. After the first four cases occurred, the multi-dose saline bottles used for CVC flushing were replaced with single-dose vials; environmental samples were negative for R. mannitolilytica. CONCLUSIONS: Although the source of R. mannitolilytica remains unidentified, CVC flushing with contaminated saline solution seems to be the most likely origin of R. mannitolilytica CVC colonization and subsequent infections. In order to prevent similar outbreaks we recommend removal of any CVC that is no longer necessary and the use of single-dose solutions for any parenteral treatment of oncology patients. BioMed Central 2017-02-07 /pmc/articles/PMC5297155/ /pubmed/28191308 http://dx.doi.org/10.1186/s13756-017-0178-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Lucarelli, Claudia
Di Domenico, Enea Gino
Toma, Luigi
Bracco, Domenico
Prignano, Grazia
Fortunati, Maria
Pelagalli, Lorella
Ensoli, Fabrizio
Pezzotti, Patrizio
García-Fernández, Aurora
Pantosti, Annalisa
Ingrosso, Loredana
Ralstonia mannitolilytica infections in an oncologic day ward: description of a cluster among high-risk patients
title Ralstonia mannitolilytica infections in an oncologic day ward: description of a cluster among high-risk patients
title_full Ralstonia mannitolilytica infections in an oncologic day ward: description of a cluster among high-risk patients
title_fullStr Ralstonia mannitolilytica infections in an oncologic day ward: description of a cluster among high-risk patients
title_full_unstemmed Ralstonia mannitolilytica infections in an oncologic day ward: description of a cluster among high-risk patients
title_short Ralstonia mannitolilytica infections in an oncologic day ward: description of a cluster among high-risk patients
title_sort ralstonia mannitolilytica infections in an oncologic day ward: description of a cluster among high-risk patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297155/
https://www.ncbi.nlm.nih.gov/pubmed/28191308
http://dx.doi.org/10.1186/s13756-017-0178-z
work_keys_str_mv AT lucarelliclaudia ralstoniamannitolilyticainfectionsinanoncologicdaywarddescriptionofaclusteramonghighriskpatients
AT didomenicoeneagino ralstoniamannitolilyticainfectionsinanoncologicdaywarddescriptionofaclusteramonghighriskpatients
AT tomaluigi ralstoniamannitolilyticainfectionsinanoncologicdaywarddescriptionofaclusteramonghighriskpatients
AT braccodomenico ralstoniamannitolilyticainfectionsinanoncologicdaywarddescriptionofaclusteramonghighriskpatients
AT prignanograzia ralstoniamannitolilyticainfectionsinanoncologicdaywarddescriptionofaclusteramonghighriskpatients
AT fortunatimaria ralstoniamannitolilyticainfectionsinanoncologicdaywarddescriptionofaclusteramonghighriskpatients
AT pelagallilorella ralstoniamannitolilyticainfectionsinanoncologicdaywarddescriptionofaclusteramonghighriskpatients
AT ensolifabrizio ralstoniamannitolilyticainfectionsinanoncologicdaywarddescriptionofaclusteramonghighriskpatients
AT pezzottipatrizio ralstoniamannitolilyticainfectionsinanoncologicdaywarddescriptionofaclusteramonghighriskpatients
AT garciafernandezaurora ralstoniamannitolilyticainfectionsinanoncologicdaywarddescriptionofaclusteramonghighriskpatients
AT pantostiannalisa ralstoniamannitolilyticainfectionsinanoncologicdaywarddescriptionofaclusteramonghighriskpatients
AT ingrossoloredana ralstoniamannitolilyticainfectionsinanoncologicdaywarddescriptionofaclusteramonghighriskpatients